$155 million for drug development to fight deadly superbugs: CARB-X
Channel: Wellcome
Date: 2018-09-05

Wellcome is a partner in CARB-X, which aims to protect humanity from the most serious bacterial threats by accelerating antibacterial product development over the next 25 years.

For more info: https://wellcome.ac.uk/news/we-are-pledging-155m-tackle-drug-resistant-infections

Follow us on Twitter: https://twitter.com/wellcometrust
Find us on Facebook: https://www.facebook.com/wellcometrust